ACUR

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 7/27/2017
Contact Info
  • 616 N. North Court
  • Suite 120
  • Palatine, IL 60067

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0000786947
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NY, USA
Year of Inc. 1935
Employees 15 a/o Feb 15, 2017
Company Officers/Contacts
Robert B. Jones CEO, President
Peter A. Clemens Senior VP, CFO, Secretary
James F. Emigh VP, Corp. Dev.
Albert Brzeczko VP, Tech. Svcs.
Robert A. Seiser Treasurer, Corporate Controller, Vice President
Company Directors
Robert B. Jones
George K. Ross
William G. Skelly
Immanuel Thangaraj
Bruce F. Wesson
Company Notes
  • Formerly=Halsey Drug Co., Inc. until 8-04
Service Providers
Accounting/Auditing Firm
BDO USA, LLP
330 North Wabash
Suite 3200
Chicago, IL, 60611
United States

BDO USA, LLP
1801 Market Street
Suite 1700
Philadelphia, PA, 19103
United States

Legal Counsel Investor Relations Firm
Not Available
ACUR Security Details
Share Structure
Market Value1 $8,767,591 a/o Nov 21, 2017
Authorized Shares 100,000,000 a/o Nov 07, 2017
Outstanding Shares 20,795,994 a/o Nov 07, 2017
-Restricted 13,079,346 a/o Nov 07, 2017
-Unrestricted 7,716,648 a/o Nov 07, 2017
Held at DTC 7,610,478 a/o Nov 07, 2017
Float Not Available
Par Value 0.01
Transfer Agent(s) Verified by Transfer Agent
Broadridge Financial Solutions, Inc.
Shareholders
Shareholders of Record 310 a/o Mar 31, 2017
Short Selling Data
Short Interest 45,238 (15.8%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security